Anti-™EM189-UBE2V1 monoclonal antibody

Pre-made anti-™EM189-UBE2V1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM189-UBE2V1/™EM189-UBE2V1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2030-Ab-1/ GM-Tg-hg-IP2030-Ab-2Anti-Human ™EM189-UBE2V1 monoclonal antibodyHuman
GM-Tg-rg-IP2030-Ab-1/ GM-Tg-rg-IP2030-Ab-2Anti-Rat ™EM189-UBE2V1 monoclonal antibodyRat
GM-Tg-mg-IP2030-Ab-1/ GM-Tg-mg-IP2030-Ab-2Anti-Mouse ™EM189-UBE2V1 monoclonal antibodyMouse
GM-Tg-cynog-IP2030-Ab-1/ GM-Tg-cynog-IP2030-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM189-UBE2V1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2030-Ab-1/ GM-Tg-felg-IP2030-Ab-2Anti-Feline ™EM189-UBE2V1 monoclonal antibodyFeline
GM-Tg-cang-IP2030-Ab-1/ GM-Tg-cang-IP2030-Ab-2Anti-Canine ™EM189-UBE2V1 monoclonal antibodyCanine
GM-Tg-bovg-IP2030-Ab-1/ GM-Tg-bovg-IP2030-Ab-2Anti-Bovine ™EM189-UBE2V1 monoclonal antibodyBovine
GM-Tg-equg-IP2030-Ab-1/ GM-Tg-equg-IP2030-Ab-2Anti-Equine ™EM189-UBE2V1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2030-Ab-1/ GM-Tg-hg-IP2030-Ab-2; GM-Tg-rg-IP2030-Ab-1/ GM-Tg-rg-IP2030-Ab-2;
GM-Tg-mg-IP2030-Ab-1/ GM-Tg-mg-IP2030-Ab-2; GM-Tg-cynog-IP2030-Ab-1/ GM-Tg-cynog-IP2030-Ab-2;
GM-Tg-felg-IP2030-Ab-1/ GM-Tg-felg-IP2030-Ab-2; GM-Tg-cang-IP2030-Ab-1/ GM-Tg-cang-IP2030-Ab-2;
GM-Tg-bovg-IP2030-Ab-1/ GM-Tg-bovg-IP2030-Ab-2; GM-Tg-equg-IP2030-Ab-1/ GM-Tg-equg-IP2030-Ab-2
Products NameAnti-™EM189-UBE2V1 monoclonal antibody
Formatmab
Target Name™EM189-UBE2V1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM189-UBE2V1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2030-Ag-1Recombinant multi-species PDES1/ ™EM189-UBE2V1/ CROC-1B protein


    Target information

    Target IDGM-IP2030
    Target Name™EM189-UBE2V1
    Gene ID387522
    Gene Symbol and SynonymsCROC-1B,CROC1B,KUA-UEV,PEDS1-UBE2V1,™EM189-UBE2V1
    Uniprot AccessionA5PLL7
    Uniprot Entry NamePDES1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000124208
    Target ClassificationN/A

    The target: ™EM189-UBE2V1, gene name: ™EM189-UBE2V1, also named as CROC-1B, CROC1B, KUA-UEV. The ™EM189-UEV mRNA is an infrequent but naturally occurring read-through transcript of the neighboring ™EM189 and UBE2V1 genes. Ubiquitin-conjugating E2 enzyme variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein produced by this transcript has UEV1 B domains but the protein is localized to the cytoplasm rather than to the nucleus. The significance of this read-through mRNA and the function of its protein product has not yet been determined. [provided by RefSeq, Oct 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.